Biochemical Relapse Following Radical Prostatectomy and miR-200a Levels in Prostate CancerBARRON, Niall; KEENAN, Joanne; GAMMELL, Patrick et al.The Prostate. 2012, Vol 72, Num 11, pp 1193-1199, issn 0270-4137, 7 p.Article

Combined affinity labelling and mass spectrometry analysis of differential cell surface protein expression in normal and prostate cancer cellsHASTIE, Claire; SAXTON, Malcolm; AKPAN, Akunna et al.Oncogene (Basingstoke). 2005, Vol 24, Num 38, pp 5905-5913, issn 0950-9232, 9 p.Article

XPA versus ERCC1 as chemosensitising agents to cisplatin and mitomycin C in prostate cancer cells : Role of ERCC1 in homologous recombination repairCUMMINGS, Michele; HIGGINBOTTOM, Karen; MCGURK, Claire J et al.Biochemical pharmacology. 2006, Vol 72, Num 2, pp 166-175, issn 0006-2952, 10 p.Article

Differential protein synthesis and expression levels in normal and neoplastic human prostate cells and their regulation by type I and II interferonsNAGANO, Kohji; MASTERS, John R; AKPAN, Akunna et al.Oncogene (Basingstoke). 2004, Vol 23, Num 9, pp 1693-1703, issn 0950-9232, 11 p.Article

False cell lines: The problem and a solutionMASTERS, John R.Cytotechnology (Dordrecht). 2002, Vol 39, Num 2, pp 69-74, issn 0920-9069, 6 p.Conference Paper

Reduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell linesWELSH, Carey; DAY, Roger; MCGURK, Claire et al.International journal of cancer. 2004, Vol 110, Num 3, pp 352-361, issn 0020-7136, 10 p.Article

Clinical features of patients who present with metastatic prostate carcinoma and serum prostate-specific antigen (PSA) levels < 10 ng/ml: The PSA negative patientsBIRTLE, Alison J; FREEMAN, Alex; MASTERS, John R. W et al.Cancer. 2003, Vol 98, Num 11, pp 2362-2367, issn 0008-543X, 6 p.Article

Mechanism of differential sensitivity to cisplatin in nasopharyngeal carcinoma cellsXIANGHONG WANG; MASTERS, John R. W; WONG, Y. C et al.Anticancer research. 2001, Vol 21, Num 1A, pp 403-408, issn 0250-7005Article

Can p53 staining be used to identify patients with aggressive superficial bladder cancer?MASTERS, John R. W; VANI, Urvi D; GRIGOR, Kenneth M et al.Journal of pathology. 2003, Vol 200, Num 1, pp 74-81, issn 0022-3417, 8 p.Article

Match criteria for human cell line authentication: Where do we draw the line?CAPES-DAVIS, Amanda; REID, Yvonne A; NAKAMURA, Yukio et al.International journal of cancer (Print). 2013, Vol 132, Num 11, pp 2510-2519, issn 0020-7136, 10 p.Article